1. Home
  2. COGT vs BBSI Comparison

COGT vs BBSI Comparison

Compare COGT & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • BBSI
  • Stock Information
  • Founded
  • COGT 2014
  • BBSI 1965
  • Country
  • COGT United States
  • BBSI United States
  • Employees
  • COGT N/A
  • BBSI N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • COGT Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • COGT 1.1B
  • BBSI 1.1B
  • IPO Year
  • COGT 2018
  • BBSI 1993
  • Fundamental
  • Price
  • COGT $12.07
  • BBSI $45.70
  • Analyst Decision
  • COGT Strong Buy
  • BBSI Strong Buy
  • Analyst Count
  • COGT 9
  • BBSI 2
  • Target Price
  • COGT $20.25
  • BBSI $45.00
  • AVG Volume (30 Days)
  • COGT 5.0M
  • BBSI 170.4K
  • Earning Date
  • COGT 08-05-2025
  • BBSI 08-06-2025
  • Dividend Yield
  • COGT N/A
  • BBSI 0.70%
  • EPS Growth
  • COGT N/A
  • BBSI 6.65
  • EPS
  • COGT N/A
  • BBSI 1.96
  • Revenue
  • COGT N/A
  • BBSI $1,171,315,000.00
  • Revenue This Year
  • COGT N/A
  • BBSI $9.74
  • Revenue Next Year
  • COGT N/A
  • BBSI $7.40
  • P/E Ratio
  • COGT N/A
  • BBSI $23.33
  • Revenue Growth
  • COGT N/A
  • BBSI 8.41
  • 52 Week Low
  • COGT $3.72
  • BBSI $31.77
  • 52 Week High
  • COGT $12.97
  • BBSI $46.07
  • Technical
  • Relative Strength Index (RSI)
  • COGT 78.82
  • BBSI 72.57
  • Support Level
  • COGT $11.93
  • BBSI $43.37
  • Resistance Level
  • COGT $12.79
  • BBSI $46.07
  • Average True Range (ATR)
  • COGT 0.74
  • BBSI 0.89
  • MACD
  • COGT 0.03
  • BBSI 0.27
  • Stochastic Oscillator
  • COGT 76.56
  • BBSI 90.19

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: